JAGSNPHARMJagsonpal Pharmaceuticals Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹223.02
▼ 0.47%Decent
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)1,486.10
P/E35.83
P/B5.73
PEG1.51
ROE %16.70
ROCE %17.10
Debt / Equity0.03
EPS6.30
Revenue Growth %9.60
Profit Growth %23.80
Dividend Yield %1.11
Promoter Holding %75.90
FII Holding %2.59
DII Holding %—
Beta-0.35
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Cup & Handle | LONG | 70% | ₹223.02 | ₹213.19 | ₹272.19 | 5.00 |
HOLDConviction 66%
The picture
- • Profit growth: 23.8% YoY
- • ROE: 16.7%
- • ROCE: 17.1%
- • Price vs SMA50: above
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • Cup & Handle signal (setup quality 70%)
Bull case
- • Profit growth: 23.8% YoY
- • ROE: 16.7%
- • ROCE: 17.1%
- • Price vs SMA50: above
Bear case
- • MACD: bearish
- • Price vs EMA21: below
- • Volume trend: 0.3x baseline
- • Max drawdown (1y): 44%
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • MACD: bearish
- • Price vs EMA21: below
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹223.02
Stop Loss
₹217.67
risk 2.4%
Target 1 (1.5R)
₹231.04
+3.6%
Target 2 (3R)
₹239.07
+7.2%
Support (20d)
₹219.87
Resistance (52w)
₹298.61
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹5.35/share
ATR (volatility)
₹9.83
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹9.83). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
77
Technical
55
Momentum
70
Risk (safety)
39